Revisiting the melanomagenic pathways and current therapeutic approaches

Area of Science:

• Oncology
• Dermatology
• Molecular Biology

Background:

• Melanoma incidence and mortality are rising globally.
• Both sun deprivation and excess sun exposure increase melanoma risk.
• Molecular subtypes, driven by UV-dependent or -independent mutations, complicate diagnosis and treatment.

Purpose of the Study:

• To review the signaling cascades involved in melanoma development.
• To identify potential druggable targets within these molecular networks.
• To elucidate novel therapeutic strategies for melanoma.

Main Methods:

• Literature review of signaling pathways in melanoma.
• Analysis of molecular subtypes and their genetic underpinnings.
• Identification of therapeutic targets based on pathway dysregulation.

Main Results:

• Melanoma development involves complex crosstalk between multiple signaling pathways.
• Genetic mutations dysregulate these pathways, leading to phenotypic heterogeneity.
• Several putative druggable targets have been identified within these networks.

Conclusions:

• Understanding melanoma molecular networks is key to overcoming treatment challenges.
• Targeting specific signaling cascades offers promise for improved melanoma therapies.
• Further research into molecular interactions can lead to better therapeutic strategies.